Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Inhibition of CDK Activity

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: 5-HT₃ Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Physiologically Informed Modification Of Drug-Induced Sleep Endoscopy.

The Journal of laryngology and otology·2026

Same author

Presenting Complaint and Diagnostic Yield of MRIs for Vestibular Schwannomas.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2026

Same author

Development and Validation of Species-Specific KASP and SCAR Markers for the Rapid Identification of the Endangered Orchid <i>Calanthe aristulifera</i>.

Plants (Basel, Switzerland)·2026

Same author

Letter: Thalamic Deep Brain Stimulation for Spasmodic Dysphonia: A Phase I Prospective Randomized Double-Blind Crossover Trial.

Neurosurgery·2026

Same author

Does floral phenotyping reflect species integrity and natural hybridization of endangered <i>Calanthe</i> species on an oceanic island?

Frontiers in plant science·2026

Same author

Sol-Gel-Derived Ge-Substituted LLZO Ceramic Coatings on Lithium-Rich Layered Oxide Cathodes for Improved Interfacial Stability.

Gels (Basel, Switzerland)·2026

Search research articles

Related Experiment Video

Updated: Jun 21, 2026

Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides

Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides

Published on: July 26, 2018

C5-Modified nucleosides exhibiting anticancer activity.

Yoon-Suk Lee¹, Sun Min Park, Hwan Mook Kim

¹Department of Chemistry, BK School of Molecular Science, Pohang University of Science and Technology, Pohang 790-784, Republic of Korea.

Bioorganic & Medicinal Chemistry Letters

|July 15, 2009

Summary

Researchers developed a straightforward synthesis for C5-modified nucleosides. These novel compounds, isoxazole and triazole derivatives, demonstrated significant anticancer activity against various human cancer cell lines.

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Experiment Videos

Last Updated: Jun 21, 2026

Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides

Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides

Published on: July 26, 2018

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Area of Science:

Medicinal Chemistry
Organic Synthesis
Cancer Research

Background:

Nucleoside analogs are crucial in anticancer drug development.
Modifications at the C5 position of nucleosides can alter their biological activity.
Developing efficient synthetic routes for novel nucleoside analogs is essential.

Purpose of the Study:

To synthesize novel C5-modified nucleosides.
To evaluate the anticancer activity of synthesized compounds against a panel of human cancer cell lines.

Main Methods:

In situ generation of nitrile oxides from oximes using a bleaching agent.
1,3-dipolar cycloaddition reactions between nitrile oxides and 5-ethynyl-2'-deoxyuridine to form isoxazole derivatives.
Synthesis of azides from benzylic bromides.
Copper-catalyzed azide-alkyne cycloaddition (click reaction) between azides and 5-ethynyl-2'-deoxyuridine to form triazole derivatives.
Anticancer activity screening against HCT15, MM231, NCI-H23, NUGC-3, PC-3, and ACHN cell lines.

Main Results:

Successful synthesis of isoxazole and triazole derivatives of 5-ethynyl-2'-deoxyuridine.
Demonstrated varying degrees of cytotoxic activity of the synthesized nucleoside analogs against the tested cancer cell lines.
Identified specific derivatives with notable activity against certain cancer types.

Conclusions:

A simple and effective method for synthesizing C5-modified nucleosides was established.
The synthesized isoxazole and triazole derivatives represent a promising class of compounds for anticancer drug discovery.
Further investigation into the structure-activity relationship and mechanism of action is warranted.